Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The […]
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The […]